These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 23100431)

  • 41. Role of CX3CR1 (fractalkine receptor) in brain damage and inflammation induced by focal cerebral ischemia in mouse.
    Dénes A; Ferenczi S; Halász J; Környei Z; Kovács KJ
    J Cereb Blood Flow Metab; 2008 Oct; 28(10):1707-21. PubMed ID: 18575457
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Regulation of tau pathology by the microglial fractalkine receptor.
    Bhaskar K; Konerth M; Kokiko-Cochran ON; Cardona A; Ransohoff RM; Lamb BT
    Neuron; 2010 Oct; 68(1):19-31. PubMed ID: 20920788
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postsynaptic mechanisms govern the differential excitation of cortical neurons by thalamic inputs.
    Hull C; Isaacson JS; Scanziani M
    J Neurosci; 2009 Jul; 29(28):9127-36. PubMed ID: 19605650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Knockout of fractalkine receptor Cx3cr1 does not alter disease or microglial activation in prion-infected mice.
    Striebel JF; Race B; Carroll JA; Phillips K; Chesebro B
    J Gen Virol; 2016 Jun; 97(6):1481-1487. PubMed ID: 26935332
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemokine fractalkine/CX3CL1 negatively modulates active glutamatergic synapses in rat hippocampal neurons.
    Ragozzino D; Di Angelantonio S; Trettel F; Bertollini C; Maggi L; Gross C; Charo IF; Limatola C; Eusebi F
    J Neurosci; 2006 Oct; 26(41):10488-98. PubMed ID: 17035533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of CX3CL1/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism.
    Liu Y; Zhang T; Meng D; Sun L; Yang G; He Y; Zhang C
    Behav Brain Res; 2020 Mar; 381():112371. PubMed ID: 31765724
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
    Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
    Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents.
    Cipriani R; Villa P; Chece G; Lauro C; Paladini A; Micotti E; Perego C; De Simoni MG; Fredholm BB; Eusebi F; Limatola C
    J Neurosci; 2011 Nov; 31(45):16327-35. PubMed ID: 22072684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and death.
    Suzuki M; El-Hage N; Zou S; Hahn YK; Sorrell ME; Sturgill JL; Conrad DH; Knapp PE; Hauser KF
    Mol Neurodegener; 2011 Nov; 6():78. PubMed ID: 22093090
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CX3CR1 RNAi inhibits hypoxia-induced microglia activation via p38MAPK/PKC pathway.
    Liu Y; Zhao T; Yang Z; Li Q
    Int J Exp Pathol; 2014 Apr; 95(2):153-7. PubMed ID: 24628787
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of fractalkine-CX3CR1 pathway in seizure-induced microglial activation, neurodegeneration, and neuroblast production in the adult rat brain.
    Ali I; Chugh D; Ekdahl CT
    Neurobiol Dis; 2015 Feb; 74():194-203. PubMed ID: 25461978
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deletion of the Fractalkine Receptor, CX3CR1, Improves Endogenous Repair, Axon Sprouting, and Synaptogenesis after Spinal Cord Injury in Mice.
    Freria CM; Hall JC; Wei P; Guan Z; McTigue DM; Popovich PG
    J Neurosci; 2017 Mar; 37(13):3568-3587. PubMed ID: 28264978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.
    Luo P; Chu SF; Zhang Z; Xia CY; Chen NH
    Brain Res Bull; 2019 Mar; 146():12-21. PubMed ID: 30496784
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine.
    Zhuang ZY; Kawasaki Y; Tan PH; Wen YR; Huang J; Ji RR
    Brain Behav Immun; 2007 Jul; 21(5):642-51. PubMed ID: 17174525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppressed pro-inflammatory response of microglia in CX3CR1 knockout mice.
    Mattison HA; Nie H; Gao H; Zhou H; Hong JS; Zhang J
    J Neuroimmunol; 2013 Apr; 257(1-2):110-5. PubMed ID: 23499256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of sex and neonatal stress on medullary microglia in rat pups.
    Baldy C; Fournier S; Boisjoly-Villeneuve S; Tremblay MÈ; Kinkead R
    Exp Physiol; 2018 Sep; 103(9):1192-1199. PubMed ID: 29920821
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signaling.
    Willemen HLDM; Eijkelkamp N; Wang H; Dantzer R; Dorn GW; Kelley KW; Heijnen CJ; Kavelaars A
    Pain; 2010 Sep; 150(3):550-560. PubMed ID: 20609517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhanced fear and altered neuronal activation in forebrain limbic regions of CX3CR1-deficient mice.
    Schubert I; Ahlbrand R; Winter A; Vollmer L; Lewkowich I; Sah R
    Brain Behav Immun; 2018 Feb; 68():34-43. PubMed ID: 28943292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Repopulating retinal microglia restore endogenous organization and function under CX3CL1-CX3CR1 regulation.
    Zhang Y; Zhao L; Wang X; Ma W; Lazere A; Qian HH; Zhang J; Abu-Asab M; Fariss RN; Roger JE; Wong WT
    Sci Adv; 2018 Mar; 4(3):eaap8492. PubMed ID: 29750189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evidence for a protective role of the CX3CL1/CX3CR1 axis in a model of amyotrophic lateral sclerosis.
    Liu C; Hong K; Chen H; Niu Y; Duan W; Liu Y; Ji Y; Deng B; Li Y; Li Z; Wen D; Li C
    Biol Chem; 2019 Apr; 400(5):651-661. PubMed ID: 30352020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.